Stromal protein βig-h3 reprogrammes tumour microenvironment in pancreatic cancer
Delphine Goehrig(Université Claude Bernard Lyon 1), Anà Hennino(Université Claude Bernard Lyon 1), Jérémy Nigri(Cold Spring Harbor Laboratory), Francesco Novelli(University of Turin), Philippe Bertolino(Université Claude Bernard Lyon 1), Paola Cappello(University of Turin), Pascale Milani(École Normale Supérieure de Lyon), Richard Tomasini(Centre de Recherche en Cancérologie de Marseille), Christelle de la Fouchardière(Aix-Marseille Université), Rémi Samain(Inserm), Roberta Curto(University of Turin), Corinne Bousquet(Centre National de la Recherche Scientifique), Gaëlle Gabiane(Université Claude Bernard Lyon 1), Zhichong Wu(Université Claude Bernard Lyon 1), Xinyi Zhang(Key Laboratory of Guangdong Province), Valérie Hervieu(Hospices Civils de Lyon), Marie Chanal(Université Claude Bernard Lyon 1), In-San Kim(Korea University), Yajie Zhao(Université Claude Bernard Lyon 1)
Cited by 133
Related Papers
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial
|The Lancet Oncology|2021|1.3k
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
|Journal of Clinical Oncology|2020|1.2k
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863
Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers
|New England Journal of Medicine|2020|766
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488